| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |